| Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings EH Alhamad, AA Al-Boukai, FA Al-Kassimi, HF Alfaleh, MQ Alshamiri, ... Radiology 260 (3), 875-883, 2011 | 127 | 2011 |
| Pulmonary function tests in interstitial lung disease: what role do they have? EH Alhamad, JP Lynch, FJ Martinez Clinics in chest medicine 22 (4), 715-750, 2001 | 86 | 2001 |
| Interstitial lung diseases in Saudi Arabia: A single-center study EH Alhamad Annals of thoracic medicine 8 (1), 33-37, 2013 | 84 | 2013 |
| Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry OA Shlobin, V Kouranos, SD Barnett, EH Alhamad, DA Culver, J Barney, ... European Respiratory Journal 55 (5), 2020 | 81 | 2020 |
| Clinical features of sarcoidosis associated pulmonary hypertension: results of a multi-national registry RP Baughman, OA Shlobin, AU Wells, EH Alhamad, DA Culver, J Barney, ... Respiratory medicine 139, 72-78, 2018 | 66 | 2018 |
| The six-minute walk test in patients with pulmonary sarcoidosis EH Alhamad Annals of thoracic medicine 4 (2), 60-64, 2009 | 59 | 2009 |
| Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients EH Alhamad, MM Idrees, MO Alanezi, AA AlBoukai, SA Shaik Annals of Thoracic Medicine 5 (2), 86-91, 2010 | 49 | 2010 |
| Pulmonary hypertension in end-stage renal disease and post renal transplantation patients EH Alhamad, M Al-Ghonaim, HF Alfaleh, JP Cal, N Said Journal of thoracic disease 6 (6), 606, 2014 | 45 | 2014 |
| Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis EH Alhamad, JG Cal, Z Shakoor, A Almogren, AA AlBoukai BMC medical genetics 14, 1-13, 2013 | 42 | 2013 |
| Comparison of three groups of patients with usual interstitial pneumonia EH Alhamad, FA Al-Kassimi, AA AlBoukai, E Raddaoui, MS Al-Hajjaj, ... Respiratory medicine 106 (11), 1575-1585, 2012 | 34 | 2012 |
| Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease FA Al-Kassimi, AA Abba, MS Al-Hajjaj, EH Alhamad, E Raddaoui, ... Respiration 82 (1), 19-27, 2011 | 30 | 2011 |
| Predictors of mortality in patients with interstitial lung disease-associated pulmonary hypertension EH Alhamad, JG Cal, NN Alrajhi, WM Alharbi Journal of Clinical Medicine 9 (12), 3828, 2020 | 26 | 2020 |
| A challenge to the seven widely believed concepts of COPD FA Al-Kassimi, EH Alhamad International journal of chronic obstructive pulmonary disease, 21-30, 2013 | 26 | 2013 |
| Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis EH Alhamad, JG Cal, NN Alrajhi, WM Aharbi, AC AlRikabi, AA AlBoukai Annals of Thoracic Medicine 15 (4), 208-214, 2020 | 22 | 2020 |
| Spirometric reference values for healthy nonsmoking S audi adults MO Al Ghobain, EH Alhamad, HS Alorainy, M Al Hazmi, MS Al Moamary, ... The clinical respiratory journal 8 (1), 72-78, 2014 | 22 | 2014 |
| Pulmonary hypertension in Saudi Arabia: A single center experience EH Alhamad, JG Cal, HF Alfaleh, MQ Alshamiri, AA AlBoukai, ... Annals of thoracic medicine 8 (2), 78-85, 2013 | 22 | 2013 |
| Interstitial lung disease: the initial approach EH Alhamad, GP Cosgrove Medical Clinics 95 (6), 1071-1093, 2011 | 20 | 2011 |
| The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry R Gupta, RP Baughman, SD Nathan, AU Wells, V Kouranos, EH Alhamad, ... Respiratory Medicine 196, 106801, 2022 | 19 | 2022 |
| Clinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia EH Alhamad Journal of Thoracic Disease 7 (3), 386, 2015 | 17 | 2015 |
| Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience EH Alhamad Annals of Thoracic Medicine 10 (1), 38-43, 2015 | 17 | 2015 |
